esmolol


Also found in: Dictionary, Thesaurus, Wikipedia.

esmolol

 [es´mo-lol]
a cardioselective beta-adrenergic blocking agent used as the hydrochloride salt in treatment of arrhythmias for short-term control of atrial fibrillation, atrial flutter, and noncompensatory sinus tachycardia.

esmolol

/es·mo·lol/ (es´mo-lol) a cardioselective β1-blocker used as the hydrochloride salt as an antiarrhythmic in the short-term control of atrial fibrillation, atrial flutter, and noncompensatory sinus tachycardia.

esmolol

Brevibloc® Cardiology An ultrashort β-blocker used to treat A fib/flutter, unstable angina, HTN, SVT, PVCs, and for 2º protection of MI survivors Contraindications Bronchospastic lung disease, left ventricular dysfunction. See β-blocker.

esmolol

a short-acting β-receptor blocking agent, used as the hydrochloride to treat cardiac arrhythmias.
References in periodicals archive ?
Landiolol is an ultra-short acting [bet]-antagonist with a half-life of three minutes that is eight times more cardioselective than esmolol.
Of the studies in this meta-analysis, only one compared the haemodynamics of landiolol and esmolol (25).
Short-acting esmolol in particular helps careful titration of heart rate.
Other than Patient 1 and 2, the other patients did not receive any esmolol at time of implantation.
Esmolol 40 mg was given and, as the device was inserted into the left ventricle and started, the cardiac output and blood pressure fell precipitously.
It is estimated that with limited or no promotion, Baxter currently sells $13M of Esmolol in the markets we will be covering.
Food and Drug Administration (FDA) for Esmolol HCl in Sodium Chloride Injection, 10mg/ml (250 ml) and 20 mg/ml (100 ml).
7 million acquisition of Aloprim (allopurinol sodium) for Injection from Nabi Biopharmaceuticals, and the acquisition of Esmolol Hydrochloride ("Esmolol") from Metrics Pharmaceutical Ventures, LLC.
We are also very pleased to have completed the acquisitions of Aloprim and Esmolol," Mr.
Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Esmolol Hydrochloride Injection, 10 mg/mL, the generic equivalent of Baxter International's Brevibloc(R) Injection.
Esmolol is the second tentative approval APP has received in 2004 and brings to eight the total number of approvals the company has received this year.